Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Gains from Sales and Divestitures (2020 - 2025)

Outset Medical has reported Gains from Sales and Divestitures over the past 5 years, most recently at $129000.0 for Q4 2025.

  • Quarterly Gains from Sales and Divestitures fell 91.49% to $129000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $129000.0 through Dec 2025, down 91.49% year-over-year, with the annual reading at $129000.0 for FY2025, 91.49% down from the prior year.
  • Gains from Sales and Divestitures was $129000.0 for Q4 2025 at Outset Medical, down from $1.5 million in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $1.5 million in Q4 2024 and troughed at $19000.0 in Q4 2021.
  • The 4-year median for Gains from Sales and Divestitures is $176500.0 (2022), against an average of $472000.0.
  • Year-over-year, Gains from Sales and Divestitures surged 1078.95% in 2022 and then crashed 91.49% in 2025.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $19000.0 in 2021, then surged by 1078.95% to $224000.0 in 2022, then surged by 576.79% to $1.5 million in 2024, then crashed by 91.49% to $129000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Gains from Sales and Divestitures are $129000.0 (Q4 2025), $1.5 million (Q4 2024), and $224000.0 (Q4 2022).